FORM4API
ExploreSearch any ticker for its insider tradesFilingsThe newest Form 4 filings, market-wideForm 144Intent to sell, filed before the trade13F FilersInstitutional 13F-HR filers by AUMSignalsCluster buy & sell signalsScreenerFilter trades by code, size & returnCongressSTOCK Act trades disclosed by Congress
PricingDocs
SEC Form 4 explainedSEC Form 144 explained13F-HR filings explainedCluster buy signals10b5-1 trading plans
All guides →
Sign inGet a key

Company profile

Crescent Biopharma, Inc. Insider Trading

CBIO

Every SEC Form 4 insider trading filing for Crescent Biopharma, Inc. (CBIO) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001253689
Filings
70
Insiders
43
Last filing
2026-07-16
SEC EDGAR ↗Yahoo Finance ↗Finviz ↗Stock Analysis ↗

Activity summary

No insider transactions in the last 30 days. The most recent was on July 16, 2026, when Fairmount Funds Management LLC bought 853,450 shares. 70 filings from 43 insiders are on record below.

Three year balance

Buy and sell value by quarter, Q2 23 to Q3 26. Crescent Biopharma, Inc. insiders are net buyers across the period shown.

Q2 23Q3 23Q4 23Q1 24Q2 24Q3 24Q2 25Q3 25Q4 25Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $20.0M.

90 day insight

Over the last 90 days, Crescent Biopharma, Inc. insiders bought $20.0M across 7 transactions with no open-market sales.

  • Most active insider: Fairmount Funds Management LLC with 3 transactions totaling $20.0M.
  • Largest single purchase: $12.4M by Fairmount Funds Management LLC on Jul 16, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue1d1w1m3m6m
Jul 16, 2026Fairmount Funds Management LLCCBIO
Purchase
853,450$14.50$12.38M+10.6%+12.5%+12.7%——
Jul 16, 2026Fairmount Funds Management LLCCBIO
Purchase
525,897$14.50$7.62M+10.6%+12.5%+12.7%——
Jun 22, 2026McNeill JonathanCBIO
Sale10b5
20,549$17.99$370K-0.8%+2.9%-2.7%——
Jun 22, 2026Bispham Barbara HarlinCBIO
Sale10b5
1,218$17.99$22K-0.8%+2.9%-2.7%——
Jun 22, 2026Pinkas JanCBIO
Sale10b5
1,288$17.99$23K-0.8%+2.9%-2.7%——

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=CBIO" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Fairmount Funds Management LLCDirector4 filings+$40.0M
Brumm Joshua TChief Executive Officer1 filing−$761K
McNeill JonathanPresident and COO1 filing−$370K
Pinkas JanChief Scientific Officer1 filing−$23K
Im Ellie EunkyungChief Medical Officer1 filing−$22K
FORM4API

Real-time SEC Form 4, Form 144, 13F-HR and congressional trading data, over a REST API and webhooks.

Data
  • Screener
  • Filings
  • Signals
  • Companies
  • Insiders
  • Congress trades
  • 13F filers
  • Explorer
  • Top insiders
Developers
  • Documentation
  • Insider trading API
  • Python SDK
  • TypeScript SDK
  • MCP server
  • Status
Company
  • Pricing
  • Guides
  • Compare
  • About
  • Data quality
  • Privacy
  • Terms
Form4API, StockholmNot affiliated with the SEC or EDGAR. Data sourced from public EDGAR filings. Not investment advice.

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.

TEAMAtlassian CorpLEGLeggett & Platt IncVZVerizon Communications IncTPLTexas Pacific Land CorpCRMSalesforce, Inc.METAMeta Platforms, Inc.RCGRENN Fund, Inc.ACNAccenture plcPPGPpg Industries IncNFLXNetflix IncCHDChurch & Dwight Co Inc /de/